Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 651–700 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
MRVIMaravai LifeSciences Holdings, Inc. Healthcare Nov 4 Sep '26 $46.0M +9.5% −$14.0M n/m −$0.09 n/m -45.0% −322.3 pp $2.1B
VCYTVeracyte, Inc. Healthcare Nov 4 Sep '26 $152M +15.2% $32.0M +68.4% $0.38 +58.3% 10.9% −6.5 pp $2.0B
HRMYHarmony Biosciences Holdings, Inc. Healthcare Nov 4 Sep '26 $269M +12.6% $48.0M −5.9% $0.81 −6.9% 20.1% −7.2 pp $1.9B
AGLagilon health, inc. Healthcare Nov 4 Sep '26 $1.52B +5.9% $35.0M n/m $1.97 n/m 1.6% +10.7 pp $1.9B
BCRXBioCryst Pharmaceuticals, Inc. Healthcare Nov 4 Sep '26 $180M +13.2% $38.0M +192.3% $0.14 +133.3% 29.6% +11.0 pp $1.9B
LMATLeMaitre Vascular, Inc. Healthcare Nov 4 Sep '26 $68.0M +11.5% $15.0M −11.8% $0.65 −13.3% 26.0% −7.2 pp $1.7B
PSNLPersonalis, Inc. Healthcare Nov 4 Sep '26 $26.0M +85.7% −$34.0M n/m −$0.32 n/m -138.8% +21.9 pp $1.6B
VIRVir Biotechnology, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$96.0M n/m −$0.57 n/m — — $1.6B
KLRAKailera Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M — −$96.0M — −$0.74 — — — $1.6B
PGENPrecigen, Inc. Healthcare Nov 4 Sep '26 $74.0M +2,367% $36.0M n/m $0.08 n/m 52.1% — $1.5B
URGNUroGen Pharma Ltd. Healthcare Nov 4 Sep '26 $89.0M +229.6% −$1.0M n/m −$0.03 n/m 9.4% +109.0 pp $1.5B
QUREuniQure N.V. Healthcare Nov 4 Sep '26 $5.0M +25.0% −$61.0M n/m −$0.88 n/m — — $1.5B
USPHU.S. Physical Therapy, Inc. Healthcare Nov 4 Sep '26 $223M +36.0% $11.0M +57.1% −$1.04 −316.7% 11.3% −4.2 pp $1.5B
PAHCPhibro Animal Health Corporation Healthcare Nov 4 Sep '26 $387M +6.3% $30.0M +11.1% $0.72 +10.8% 12.8% −0.3 pp $1.4B
DMRADamora Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$32.0M n/m −$0.40 n/m — — $1.4B
NUVBNuvation Bio Inc. Healthcare Nov 4 Sep '26 $45.0M +246.2% −$42.0M n/m −$0.12 n/m -93.9% +336.2 pp $1.4B
PRCTPROCEPT BioRobotics Corporation Healthcare Nov 4 Sep '26 $98.0M +18.1% −$27.0M n/m −$0.46 n/m -27.9% −0.0 pp $1.4B
INVAInnoviva, Inc. Healthcare Nov 4 Sep '26 $106M −1.9% −$74.0M −182.2% −$1.03 −195.4% 39.7% +7.6 pp $1.3B
STAASTAAR Surgical Company Healthcare Nov 4 Sep '26 $83.0M −12.6% $6.0M −33.3% $0.11 −38.9% 6.5% −13.0 pp $1.3B
PNTGThe Pennant Group, Inc. Healthcare Nov 4 Sep '26 $302M +31.9% $10.0M +66.7% $0.26 +52.9% 5.5% +1.0 pp $1.3B
MLYSMineralys Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$57.0M n/m −$0.64 n/m — — $1.3B
OPKOpko Health, Inc. Healthcare Nov 4 Sep '26 $65.0M n/m −$54.0M n/m −$0.07 n/m -48.0% — $1.2B
RAPPRapport Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$40.0M n/m −$0.84 n/m — — $1.1B
MLTXMoonLake Immunotherapeutics Healthcare Nov 4 Sep '26 $0.0M n/m −$80.0M n/m −$0.93 n/m — — $957M
ODTXOdyssey Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M — −$53.0M — −$1.11 — — — $931M
CTKBCytek Biosciences, Inc. Healthcare Nov 4 Sep '26 $53.0M +1.9% −$6.0M n/m −$0.05 n/m -15.8% +1.8 pp $745M
SLDBSolid Biosciences Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$54.0M n/m −$0.36 n/m — — $695M
NVCTNuvectis Pharma, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$30.0M n/m −$1.02 n/m — — $660M
GERNGeron Corporation Healthcare Nov 4 Sep '26 $60.0M +27.7% $1.0M n/m $0.00 n/m 9.5% +38.9 pp $644M
DSGNDesign Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$20.0M n/m −$0.32 n/m — — $630M
SGHTSight Sciences, Inc. Healthcare Nov 4 Sep '26 $25.0M +25.0% −$7.0M n/m −$0.12 n/m -24.6% +15.1 pp $583M
PACBPacific Biosciences of California, Inc. Healthcare Nov 4 Sep '26 $41.0M +7.9% −$38.0M n/m −$0.12 n/m -91.2% +9.7 pp $568M
MYGNMyriad Genetics, Inc. Healthcare Nov 4 Sep '26 $203M −1.5% −$44.0M n/m −$0.46 n/m -19.7% −8.3 pp $531M
TKNOAlpha Teknova, Inc. Healthcare Nov 4 Sep '26 $13.0M +30.0% −$3.0M n/m −$0.06 n/m -25.2% +13.2 pp $481M
EOLSEvolus, Inc. Healthcare Nov 4 Sep '26 $77.0M +11.6% −$13.0M n/m −$0.19 n/m -10.9% +5.8 pp $443M
VMDViemed Healthcare, Inc. Healthcare Nov 4 Sep '26 $81.0M +12.5% $5.0M +25.0% $0.11 +22.2% 8.6% +0.1 pp $344M
LYELLyell Immunopharma, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$46.0M n/m −$1.86 n/m — — $336M
QTTBQ32 Bio Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$9.0M n/m −$0.26 n/m — — $258M
OCGNOcugen, Inc. Healthcare Nov 4 Sep '26 $2.0M 0.0% −$4.0M n/m −$0.01 n/m -909.9% — $257M
LFCRLifecore Biomedical, Inc. Healthcare Nov 4 Sep '26pending $25.3M† −18.3% — — — — — — $242M
ACIUAC Immune SA Healthcare Nov 4 Sep '26 $3.9M +200.0% — n/m −$0.16 n/m -302.1% — $215M
NAGENiagen Bioscience, Inc. Healthcare Nov 4 Sep '26 $27.0M −20.6% −$1.0M −120.0% −$0.01 −120.0% -5.8% −18.3 pp $162M
OKUROnKure Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$18.0M n/m −$0.36 n/m — — $104M
STIMNeuronetics, Inc. Healthcare Nov 4 Sep '26pending $42.0M† +13.4% — — — — — — $99M
SERASera Prognostics, Inc. Healthcare Nov 4 Sep '26pending $0.0M† n/m — — — — — — $78M
TNYATenaya Therapeutics, Inc. Healthcare Nov 4 Sep '26pending $1.7M† n/m — — — — — — $74M
GEGGreat Elm Group, Inc. Healthcare Nov 4 Sep '26pending $3.3M† −69.7% — — — — — — $66M
OMOutset Medical, Inc. Healthcare Nov 4 Sep '26pending $33.6M† +15.9% — — — — — — $60M
CLNNClene Inc. Healthcare Nov 4 Sep '26 $0.0M n/m $4.0M n/m $0.05 n/m — — $46M
ECORelectroCore, Inc. Healthcare Nov 4 Sep '26 $10.0M +11.1% −$1.0M n/m −$0.13 n/m -16.1% +17.1 pp $44M
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.